Net Power Optimization Based on Extremum Search and Model-Free Adaptive Control of PEMFC Power Generation System for High Altitude
IEEE Transactions on Transportation Electrification · 2023-12 · 9 (4) · 5151-5164
DOI: 10.1109/tte.2022.3222970 ↗Kurz gefasst
Fachartikel in der Zeitschrift IEEE Transactions on Transportation Electrification, 2023-12. Verfasst von Shuo Li und 6 weiteren Autor:innen. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation, Key Project of Natural Science Foundation of Sichuan Province, Fok Ying-Tong Education Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation
- Key Project of Natural Science Foundation of Sichuan Province
- Fok Ying-Tong Education Foundation of China
- NEEC Open-End Fund of China
- 14th Five-Year Major Science and Technology Research Project of China Railway Rolling Stock Corporation
Zitieren
APA
Li, S., Qiu, Y., Yin, L., Li, R., Gan, R., Li, Q., & Huangfu, Y. (2023). Net Power Optimization Based on Extremum Search and Model-Free Adaptive Control of PEMFC Power Generation System for High Altitude. IEEE Transactions on Transportation Electrification, 9(4), 5151-5164. https://doi.org/10.1109/tte.2022.3222970
Vancouver
Li S, Qiu Y, Yin L, Li R, Gan R, Li Q, et al. Net Power Optimization Based on Extremum Search and Model-Free Adaptive Control of PEMFC Power Generation System for High Altitude. IEEE Transactions on Transportation Electrification. 2023;9(4):5151-5164. doi:10.1109/tte.2022.3222970
BibTeX
@article{Li2023,
author = {Li, Shuo and Qiu, Yibin and Yin, Liangzhen and Li, Ruirui and Gan, Rui and Li, Qi and Huangfu, Yigeng},
title = {Net Power Optimization Based on Extremum Search and Model-Free Adaptive Control of PEMFC Power Generation System for High Altitude},
journal = {IEEE Transactions on Transportation Electrification},
year = {2023},
volume = {9},
number = {4},
pages = {5151--5164},
doi = {10.1109/tte.2022.3222970}
}
EUVIMED